Armstrong, K., Eisen, A., and Weber, B. (2000): Assessing the risk of breast
DAFTAR PUSTAKA American Cancer Society (2010): Breast Cancer Facts and Figures 2009-2010.
/f861009final90809pdf.pdf Antoine, C., Leibens, F., Carly, B., Pastijn, A. and Rozenberg, S. (2004):
Influence of HRT on prognostic factors for breast cancer: a systematic review after the women's health initiative trial. Hum. Reprod., 19: 741-56.
Armstrong, K., Eisen, A., and Weber, B. (2000): Assessing the risk of breast . New Engl. J. Med., 342: 564-71.
cancer
Autier, P. (2002): A breast cancer screening program operating in a liberal health
care system: the Luxembourg Mammography Program, 1992-1997. Int. J. Cancer, 97:
828-32.Axilbund, J.E., Gross, A.L., Visvanathan, K. ( 2011): Chapter 5 in Early diagnosis Jacobs L. and Finlayson C.A (Ed) and treatment of cancer Series: Breast Cancer. Saunders Elsevier: pp 71-88.
Backus, J., Laughlin, T., Wang, Y., Belly, R., Robert, W., Baden, J., Min, C. J., Mannie, A., Tafra, L., Atkins, D. and Verbanac, K.M. (2005): Identification and
characterization of optimal gene expression markers for detection of breast cancer metastasis. Journal of Molecular Diagnostics, 7:327 –336.
Bae J.W., Choi K.H., Kim H.G., Park S.H. (2000): The detection of circulating
breast cancer cells in peripheral blood by Reverse Transcriptase-Polymerase Chain
J. Korean Med Sci, 15: 194-8. Reaction.Bernstein J.L., Godbold J.H., Raptis G., Watson M.A., Levinson B., Aaronson S.A., Fleming T.P.(2005): Identification of Mammaglobin as a Novel Serum Marker
Clin Cancer Res, 11:6528-6535 for Breast Cancer. Bitisik, O., Saip, P., Saglam, S., Derin, D. And Dalay, N. (2009): Mammaglobin
and maspin transcripts in blood may reflect disease progression and the effect of therapy in breast cancer. Genetics and Molecular Research 9(1): 97-106
Brekelmans, C.T., Seynaeve C., Bartels, C.C., Verhoog, L.C., Van Den, O.A., Obdeijn, I.M. and Klijin, J.G. (2001): Effectiveness of breast cancer surveillance in
BRCA 1/2 gene mutation carriers and women with high familial risk . J. Clin. Oncol.,
19: 924-30.Canda, M.S., Gury, M., Erbayraktar, R.S., Acar, F. and Canda, T. (2004):
Association of invasive breast Carcinoma and Glioblastoma multiforme: a case
report with histological and immunohistochemical features. Turk. J. Med. Sci., 34:
131-135.Carter, D., Dillon, D.C., Reynolds, L.D., Retter, M.W., Fanger , G., Molesh, D.A., Sleath, P.R., McNeill, P.D., Vedvick, T.S., Reed, S.G., Persing, D.H. and Houghton, R.L.( 2003): Serum antibodies to lipophilin-B detected in
late stage breast cancer patients. Clin. Cancer Res., 9:749-754.
Cerveira, N., Torres, L., Rocha, P., Bizarro, S., Pereira, D., Abreu, J., Teixeira, M.R. and Castedo, S. (2004): Highly sensitive detection of the MGB1 transcript
(mammaglobin) in the peripheral blood of breast cancer patients. Int. J. Cancer, 108:
–595.Collado, M., Landt, O., Barragán, E., Lass, U., Cervera, J., Sanz, M. A. And Bolufer, P. (2004): Locked nucleic
acid-enhanced detection of 1100delC*CHEK2 germ-line mutation in Spanish patients with hematologic malignancies. Clin. Chem., 50: 2201 - 2204.
Connor, E. and Stuenkel, C.A. (2001): Hormone replacement therapy (HRT)-risks . Int. J. Epidemiol., 30: 423-6.
and benefits
Corradini, P., Voena, C., Astolfi, M., Dell´Oro, S., Pilotti, S., Arrigoni, G., Bregni, M., Pileri, A. and Gianni, A.M. (2001): Maspin and mammaglobin genes are
specific markers for RT-PCR detection of minimal residual disease in patients with breast
Ann. Oncol., 12: 1693 cancer.
- –1698. Cristofanilli, M., Hayes, D.F., Budd, G. T., Ellis, M.J., Stopeck, A., Reuben, J.M., Doyle, G.V., Matera, J., Allard, W.J., Miller, M. C., Fritsche, H.A., Hortobagyi, G.N. and Terstappen, L.W.M.M. (2005): Circulating
Tumor Cells: A novel prognostic factor for newly diagnosed metastatic breast cancer. Journal of Clinical Oncology, 23(7): 1420-1430.
De Jong, M.M., Nolte, I. M., te Meerman, G.J., Van Der Graaf, W.T., Oosterwikjk, J.C., Kleibeuker, J.H., Schaapveld M. and De Vries E. G. (2002): Genes
other than BRCA1 and BRCA2 involved in breast cancer susceptibility, J. Med.
Genet., 39: 225-42.
De la Hoya, M., Gutiérrez-Enríquez, S., Velasco, E., Osorio, A., de Abajo, A.S., Vega, A., Salazar, R., Esteban, E., Llort, G., Gonzalez-Sarmiento, R., Carracedo, A., Benítez, J., Miner, C., Díez, O., Díaz-Rubio, E. and Caldes, T. (2006): Genomic
Rearrangements at the BRCA1 Locus in Spanish families with breast ovarian cancer .
Clin. Chem., 52: 1480-1485 Duffy, M.J. (2005): Predictive markers in breast and other cancers. Clin. Chem., 51: 494 –503. Duffy, M.J. (2006): Serum tumor markers in breast cancer: Are they of clinical value? Clin. Chem., 52: 345-51.
Elahi, M., Norat, T., Goudable, J. and Riboli, E. (2004):Biomarkers of dietary fat
intake and the risk of breast cancer: A meta-analysis. Int. J. Cancer, 111: 584-91.
Elmore, J.G., Miglioretti, D.L. and Carney, P.A. (2005):
Does practice make mammography? part II. J. Natl. Cancer Inst., 95:250-2
El-Sharkawy S.L., El-Aal W.S.A., El-Shaer M.A.M., Abbas N.F., Youssef, M.F.(2007): Mammaglobin: A novel tumor marker for breast cancer,Turkish Journal of Cancer 37 (3) : 89-97.
Ergul E. and Sazci A.(2001): Molecular Genetics of Breast Cancer. Turk J Med Sci 31: 1-14 Frazier, A.L., Ryan, C.T., Rockett, H., Willett, W.C. and Colditz, G.A. (2003):
Adolescent diet and risk of breast cancer. Breast Cancer Res., 5: R59-R64
Gasco, M., Shami, S. and Crook, T. (2002): The p53 pathway in breast cancer. Breast Cancer Res., 4: 70-76.
Giard, R.W.M. and Hermans, J. (1992): The value of aspiration cytology of the breast. Cancer, 69: 2104-2110. Gillanders, W.E. (2005): Clinical translation of a Mammaglobin-A DNA vaccine
. Ph.D. Thesis, Washington University School of
for Breast Cancer Therapy Medicine.
Giordano, S.H. (2005): A review of the diagnosis and management of male breast Oncologist, 10: 471-9.
cancer.
Grebenchtchikov, N., Brinkman, A., van Broekhoven, S. P.J., de Jong, D., Geurts- Moespot, A. , Span, P. N., Peters, H. A., Portengen, H. , Foekens, J.A., Sweep, C.G.J.
(Fred) and Dorssers, L.C.J. (2004): Development
of an ELISA for measurement of BCAR1 protein in human breast cancer tissue . Clinical Chemistry, 50:1356-1363.
Grünewald, K., Haun, M., Urbanek ,M., Fliegl, M., Mueller-Holzner, E., Gunsilius, E., Dünser, M., Marth, C. and Gastl, G. (2000): Mammaglobin gene
expression: a superior marker of breast cancer cells in peripheral blood in
- – comparison to epidermal-growth-factor and cytokeratin-19. Lab. Invest., 80: 1071 1077.
Guadagni, F., Ferroni, P., Carlini, S., Mariotti, S., Spila, A., Aloe, S., D´Alessandro, R., Carone, M.D., Cicchetti, A., Riccoiotti, A., Venturo, I., Perri, P., Filippo, F. D., Cognetti, F., Botti, C. and Roselli, M. (2001):
A reevaluation of carcinoembryonic antigen (CEA) as a serum marker for breast cancer. Clin. Cancer Res., 7: 1257- 2362.
Harbeck, N., Kates, R.E., Look, M.P., Gelder, M.M., Klijn, J.G.M. and Kruger, A.
from adjuvant chemotherapy in breast cancer patients classified high-risk according to urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitor type 1 (N = 3424). Cancer Res., 62: 4617–4622.
Harris L., Fritsche H., Mennel R., Norton L., Ravdin P., Taube S., Somerfield M.R., Hayes D.F.,and Bast Jr R.C.(2007): American Society of Clinical Oncology
2007 Update of Recommendations for the Use of Tumor Marker in Breast Cancer . J.
of Clin. Onc. 25(33): 5287-5312.Hellström, L., Goodman, G., Pullman, J., Yang, Y. and Hellström, K. E. (2001):
Overepreesion oh HER-2 in ovarian carcinoma. Cancer Research, 61: 2420-2423
Henry, N.L. and Hayes, D.F. (2006): Uses and abuses of tumor markers in the .
diagnosis monitoring and treatment of primary and metastatic breast cancer Oncologist, 11(6)541-52.
Jemal, A.; Siegel, R.; Ward, E.; Murray, T.; Xu, J. And Thun, M. J. (2007): . CA Cancer J. Clin., 57:43-66.
Cancer statistics, 2007
Jones G. (1999): CA 15-3. SydPath. Koga, T., Horio, Y., Mitsudomi, T., Takahashi, T. and Yatabe, Y. (2004):
Identification of MGB1 as a marker in the differential diagnosis of lung tumors in patients with a history of breast cancer by analysis of publicly available SAGE data.
J. Mol. Diagn, 6(2): 90-95.
Lacroix M.(2006): Significance, detection and markers disseminated breast
cancer cells . Endocrine-Related Cancer, 13: 1033 –1067.
Lee I.M., Cook N.R., Rexrode K.M. and Buring J.E. (2001): Lifetime physical . British Journal of Cancer., 85(7), 962
activity and risk of breast cancer
- –965 Loman, N., Bladström, A. Johannsson, O., Borg, A. And Olsson, H. (2003):
Cancer incidence in relatives of a population- based set of cases of early- onset breast cancer with a known BRCA1 and BRCA2 mutation status. Breast Cancer Res., 5: R175- R186.
Margolese R.G., Fisher B., Hortobagyi G.N. and Bloomer W.D.(2003): Chapter
118 Neoplasms of the Breast : Cancer Medicine, 6th Edition"
McTieranan, A., Rajan, K.B., Tworoger, S.S., Irwin, M., Bernstein, L., Baumgartner, R., Gilliland, F., Stanczyk, F.Z., Yasui, Y. and Ballard-Barbash, R. Journal of Clinical Oncology, 21: 1961-6. Mikhitarian, K., Martin, R.H., Ruppel, M. B., W.E. Gillanders, W.E., Hoda, R., Schutte, D.H., Callahan, K., Mitas, M. and Cole, D.J. (2008): Detection of
mammaglobin mRNA in peripheral blood is associated with high grade breast cancer: Interim results of a prospective cohort study. BMC. Cancer, 8:55.
Miksicek, R.J., Myal, Y., Watson, P.H., Walker, C., Murpohy,L.C. and Leygue, E. (2002): Identification of a
novel breast-and salivary gland-specific, Mucin-like gene strongly expressed in normal and tumor human mammary epithelium. Cancer Res., 62: 2736-2740.
Molina, R., Barak, V., van Dalen, A., Duffy, M.J., Einarsson, R. and Gion, M. (2005): Tumor markers in
breast cancer: European Group of Tumor Markers (EGTM) recommendations. Tumor Biol., 26: 281–293.
Notani, P.N.(2001): Global variation in cancer incidence and mortality. Current science, Vol. 81, No. 5 Núñez-Villar, M.J., Martinez-Arribas, F., Pollan, M., Lucas, A.R., Sánchez, J., Tejerina, A. and Schneider, J. (2003): Elevated mammaglobin (h-MAM) expression in
breast cancer is associated with clinical and biological features defining a less . Breast Cancer Res.,5(3): R65-70. aggressive tumor phenotype
Oakley, K.L., Going, J.J. (1995): Specimen slice radiography of cancer in breast
conserving excisions. J.Clin. Pathol 48:1028-30
O'Brien, N., Maguire, T.M., O'Donovan, N., Lynch, N., Hill, A. D.K., McDermott,
Passebosc-Faure, K., Li, G., Lambert, C., Cottier, M., Gentil-Perret, A., Fournel, P.; Pérol, M. and Genin, C. (2005): Evaluation of a panel of molecular markers for
the diagnosis of malignant serous effusions. Clin. Cancer Res.,11(19).
Perkins G.L., Slater E.D., Sanders G.K., Prichard J.G.(2007): Serum Tumor Markers. American Family Physician, 68 (6): 1075-82. Peto, J. (2002): Breast cnacer susceptibility: A new look at an old model.,Cancer Cell, 1: 411-2. Poschl, G. and Seitz, H.K. (2004): Alcohol and cancer. Alcohol, 39: 155-65. Raina, V., Bhutani, M., Bedi, R., Sharma, A., Deo, S.V., Shukla, N.K., Mohanti, B.K. and Rat, G.K. (2005): Clinical features and prognostic factors of early breast cancer at a major cancer center in North India. Indian J. Cancer, 42: 40-5. Raynor, M., Stephenson, S.A., Walsh, D.C.A., Pittman, K.B. and Dobrovic, A. (2002): Optimization of the RTPCR
detection of immunomagnetically enriched carcinoma cells. Cancer, 2:14-21.
Roncella, S., Ferro, P., Bacigalupo, B., Pronzato, P., Tognoni, A., Falco, E., et al (2005): Human mammoglobin m-RNA is a reliable molecular marker for detecting
J. Exp. Clin. Cancer Res., 24.2 occult breast cancer cells in peripheral blood. Roncella, S., Ferro, P., Bacigalupo,B., Dessanti, P., Giannico A., Gorji, N., et al (2006): Relationship between Human Mammaglobin mRNA Expression in Breast
. J. Exp. Clin. Cancer
Cancer Tissue and Clinico-Pathology features of the Tumor
Res., 25.1 Ross, J.S., Fletcher, J.A., Linette, G.P., Clark, E., Ayers, M. And Symmans, W.F. (2003): The HER-2/neu and
protein in breast cancer 2003: biomarker and target of
Oncologist, 8: 307 therapy.
- –325.
mammaglobin RT-PCR assay for detection of occult breast cancer cells in hematopoietic products. Ann. Oncol., 13: 442–429.
Singletary, S.E., Greene, F.L., Sobin, L.H. (2003): Classification of Isolated
Tumor Cells Clarification of the 6th Edition of the American Joint on Cancer Staging Manual. American Cancer Society.
Singletary, S. E. and Connolly, J.L. (2006): Breast Cancer Staging: Working with CA Cancer J. Clin., 56:37-47.
the sixth edition of the AJCC Cancer Staging Manual.
Sjödin, A. (2005): Human Secretoglobins in Normal and Neoplastic Cells and Tissues. Medical dissertation, University of Umeå, Sweden. Slamon, D.J., Leyland-Jones, B., Shak, S., Fuchs, H., Paton, V. and Bajamonde,
A. (2001): Use of
chemotherapy plus a monoclonal antibody against HER- 2 for –92.
Smigal, C., Jemal, A., Ward, E., Cokkinides, V., Smith, R., Howe, H. L. And Thun, M. (2006): Trends in breast cancer by race and ethnicity: Update 2006. CA Cancer J.Clin., 56:168-183.
Span, P.N., Waanders, E., Manders, P., Heuvel, J., Foekens, J.A., Waston, M.A. and Sweep, F. (2004): Mammaglobin is associated with low-grade, steroid
receptor- positive breast tumors from postmenopausal patients, and has independent prognostic value for relapse free survival time. J. Clin. Oncol., 22(4): 691-698.
Stewart, S.L., King, J.B., Thompson, T.D., Friedman, C and Wingo, P.A. (2004) : Morbidity and mortality Cancer mortality surveillance United States, 1990-2000. WeeklyReport, 53: 1-108.
Terry, P.D. and Rohan, T.E. (2002): Cigarette smoking and the risk of breast cancer in women. Cancer Epidem., 11: 953-971. Tjindarbumi D and Mangunkusumo R.(2002): Cancer in Indonesia, Present and
Future. Jpn J. Clin. Oncol; 32(Supplement 1)S17-S21
Tryggevadottir, L., Olafsdottir, E.J., Gudlaugsdottir, S., Jonasson, J.G. and Tulinius, H. (2003): BRCA2 mutation
carriers, reproductive factors and breast BreastCancer Res., 5: R121-R128. cancer risk. Ursin, G., Bernstein, L., Lord, S., Karim, J.R., Deapen, D., Press, M.F., Daling, J.R., Norman, S.A., Liff, J.M. and Marchbanks, P.A. (2005): Reproductive factors
and
subtypes of breast cancer defined by hormone receptor and histology. Br. J.
Cancer, 93: 364-71. Watson, M.A. and Fleming, T.P. (1996): Mammaglobin, a mammary-specific member of the uteroglobin gene family, is overexpressed in human breast cancer. Cancer Res., 56(4): 860-865. Watson, M.A., Darrow, C., Zimonjic, D.B., Popescu, N.C. and Fleming, T.P. (1998): Structure and
transcriptional regulation of the human mammaglobin gene, a breast cancer associated member of the uteroglobin gene family localized to chromosome 11q13 . Oncogene, 16(6): 817-824.
Watson, M.A., Dintzis, S., Darrow, C.M., Voss, L.E., Pipersio, J., Jensen, R. and Fleming, T.P. (1999): Mammaglobin expression in primary, metastatic, and occult Winchester D.P. (1992): Physical Examination of the Breast. Cancer Supplement, Volume 69, No. 7 Wood, W.C., Muss, H.B., Solin, L.J., Olopade, O.I. (2005): Malignant Tumors of the breast Cancer . In: Principles and Practice of Oncology.7th Ed, V.T. DeVita, S.
Hellman, S.A. Rosenberg(Eds). Philadelphia, Lippincott Williams & Wilkins, pp: 1415-77 Woodward, W.A., Strom, E.A., Tucker, S.L., McNeese, M.D., Perkins, G.H., Schechter, N.R., Singletary, S.E., Theriault, R.L., Hortobagyi, G.N., Hunt, K.K. and Thomas A. Buchholz (2003): Changes in the 2003 American Joint Committee on
Cancer Staging for Breast Cancer Dramatically Affect Stage-Specific Survival.
Journal of Clinical Oncology, 21 (17): 3244-3248 Wrensch, M.,Chew, T., Farren, G., Barlow, J., Belli, F., Clarke, C., Erdmann, C.A., Lee, M., Moghadassi, M., Peskin-Mentzer, R., Quesenberry Jr, C.P., Souders- Mason, V., Spence, L., Suzuki, M. and Gould, M. (2003): Risk factors for breast
cancer in a population with high incidence rates. Breast Cancer Research, 5 (4)
Zach, O., Kasparu, H., Krieger, O., Hehenwarter, W., Girschikofsky, M. and Lutz,
D. (1999): Detection of
circulating mammary carcinoma cells in the peripheral blood of breast cancer patients via a nested reverse transcriptase polymerase chain
. J. Clin. Oncol., 17: 2015
reaction assay for mammaglobin mRNA –2019.
Zehentner, B. K., Persing, D. H., Deme, A., Toure, P., Hawes, S. E., Brooks, L., Feng, Q., Hayes, D. C., Critichlow, C. W., Houghton, R. L.and Kiviatet, N. B. (2004): Mammaglobin as a Novel Breast Cancer Biomarker: Multigene Reverse Transcription-PCR Assay and Sandwich ELISA. Clinical Chemistry, 2069 –2076. Zhang, S.M., Manson, J.E., Rexrode, K.M., Cook, N.R., Buring, J.E. and Lee, I.M. (2007): Use of oral conjugated estrogen alone and risk of breast cancer. Am. J. Epidemiol.,165(5):524-529.